Radiation sensitizing agents in clinical radiation and chemotherapy.
Copyright policy )Radiation sensitizing agents in clinical radiation and chemotherapy.
Patients with bronchogenic carcinoma or with advanced pediatric solid tumours were treated with various radiation therapy schedules alone or with a new alkylating carbamate: AB 132. Drug therapy appeared to potentiate radiation therapy results without significant toxicity except for certain neurologic symptoms (myasthenia, nightmares, disturbances of taste and smell). The latter appeared to be related to acetylcholinesterase and pseudocholinesterase inhibition.
Male, Clinical Trials as Topic, Radiation-Sensitizing Agents, Lung Neoplasms, Azirines, Aziridines, Palliative Care, Random Allocation, Carcinoma, Bronchogenic, Neoplasms, Humans, Female, Child
Male, Clinical Trials as Topic, Radiation-Sensitizing Agents, Lung Neoplasms, Azirines, Aziridines, Palliative Care, Random Allocation, Carcinoma, Bronchogenic, Neoplasms, Humans, Female, Child
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).1 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!